2017
Vitrectomy in the management of diabetic macular edema in treatment-naïve patients
Michalewska Z, Stewart MW, Landers MB, Bednarski M, Adelman RA, Nawrocki J. Vitrectomy in the management of diabetic macular edema in treatment-naïve patients. Canadian Journal Of Ophthalmology 2017, 53: 402-407. PMID: 30119796, DOI: 10.1016/j.jcjo.2017.10.011.Peer-Reviewed Original ResearchConceptsTreatment-naïve diabetic macular edemaDiabetic macular edemaCentral retinal thicknessPars plana vitrectomyMacular edemaVisual acuityPlana vitrectomyMean central retinal thicknessDuration of diabetesProspective randomized trialsTreatment-naïve patientsInitial visual acuityVisual acuity changesPrimary outcome measureEfficacy of vitrectomyElectronic medical recordsEarly vitrectomyIntravitreal bevacizumabFinal BCVAMean BCVAPrimary endpointRetinal thicknessConsecutive patientsRandomized trialsRetrospective studyCharacteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom
Alasil T, Munoz N, Keane PA, Tufail A, Coady PA, Novais E, de Carlo TE, Baumal CR, Waheed NK, Duker JS, Adelman RA. Characteristics and racial variations of polypoidal choroidal vasculopathy in tertiary centers in the United States and United Kingdom. International Journal Of Retina And Vitreous 2017, 3: 9. PMID: 28428893, PMCID: PMC5392942, DOI: 10.1186/s40942-017-0060-4.Peer-Reviewed Original ResearchPolypoidal choroidal vasculopathyFinal visual acuityWorse visual outcomeVisual acuityBilateral diseaseVisual outcomeTertiary centerFemale predominanceChoroidal vasculopathyDiagnosis of PCVInitial visual acuityRacial variationMulticenter retrospective studyLength of followDifferent treatment modalitiesSignificant decreaseIndocyanine green angiography imagesLens statusPCV patientsVision gainInitial presentationRetrospective studyWorse visionPolypoidal lesionsTreatment modalities
2014
Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration in Previously Treated Patients
Hall LB, Zebardast N, Huang JJ, Adelman RA. Aflibercept in the Treatment of Neovascular Age-Related Macular Degeneration in Previously Treated Patients. Journal Of Ocular Pharmacology And Therapeutics 2014, 30: 346-352. PMID: 24552305, DOI: 10.1089/jop.2013.0188.Peer-Reviewed Original ResearchMeSH KeywordsAged, 80 and overAntibodies, Monoclonal, HumanizedBevacizumabFemaleHumansIntravitreal InjectionsMacular DegenerationMaleRanibizumabReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsRetinaRetrospective StudiesTomography, Optical CoherenceTreatment OutcomeVascular Endothelial Growth Factor AVisual AcuityConceptsAge-related macular degenerationCentral macular thicknessAflibercept injectionsInitial visitMacular degenerationAnti-vascular endothelial growth factor treatmentNeovascular age-related macular degenerationEndothelial growth factor treatmentCentral macular edemaIntraocular pressure increaseSubset of patientsMain outcome measuresOptical coherence tomographyGrowth factor treatmentMacular thicknessNeovascular AgeOcular hypertensionSubmacular fluidVisual outcomeMacular edemaRetrospective studyVisual acuityOutcome measuresStudy populationPatients
2013
Strategy for the Management of Complex Retinal Detachments The European Vitreo-Retinal Society Retinal Detachment Study Report 2
Adelman RA, Parnes AJ, Sipperley JO, Ducournau D, Group E. Strategy for the Management of Complex Retinal Detachments The European Vitreo-Retinal Society Retinal Detachment Study Report 2. Ophthalmology 2013, 120: 1809-1813. PMID: 23601805, DOI: 10.1016/j.ophtha.2013.01.056.Peer-Reviewed Original ResearchConceptsRhegmatogenous retinal detachmentGiant retinal tearsRetinal detachmentScleral buckleComplex retinal detachmentChoroidal detachmentRetinal tearsGrade CGrade B proliferative vitreoretinopathyLow failure rateComplex rhegmatogenous retinal detachmentRetinal detachment repairFailure rateProcedure of choiceSignificant differencesMethod of repairSignificant hypotonyClinical manifestationsDetachment repairGiant tearsRetrospective studyMacular holePrimary procedureProliferative vitreoretinopathyLarge tears
2012
Is Intravitreal Bevacizumab an Effective Treatment Option for Nonarteritic Anterior Ischemic Optic Neuropathy?
Prescott CR, Sklar CA, Lesser RL, Adelman RA. Is Intravitreal Bevacizumab an Effective Treatment Option for Nonarteritic Anterior Ischemic Optic Neuropathy? Journal Of Neuro-Ophthalmology 2012, 32: 51-53. PMID: 22269947, DOI: 10.1097/wno.0b013e318240596e.Peer-Reviewed Original ResearchConceptsNonarteritic anterior ischemic optic neuropathyAnterior ischemic optic neuropathyIschemic optic neuropathyVisual acuityIntravitreal bevacizumabOptic neuropathyTreatment optionsIntravitreal bevacizumab injectionEffective treatment optionVisual field defectsBevacizumab injectionFellow eyesClinical outcomesRetrospective studyTreatment modalitiesNatural courseField defectsPatientsDecreased acuitySmall seriesAcuityBevacizumabProfound lossVisual fieldNeuropathy